Inflammatory Mediators in Erythema Migrans

Plain-language summary

This study examined inflammatory mediators in erythema migrans, an early sign of Lyme disease, and compared 7-day versus 14-day courses of the drug Doxycycline. Patients over 18 with erythema migrans were eligible. The study had no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

University Medical Centre Ljubljana

Intervention

Doxycycline 7 days, Doxycycline 14 days

Start date

6/1/2017

Estimated completion

10/31/2020

Countries

Slovenia

Related genes

Locations

• Ljubljana, Slovenia

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* erythema migrans in patients \> 18 years

Exclusion Criteria:

* pregnancy or immunocompromising conditions
* taking antibiotic with antiborrelial activity within 10 days